SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001477932-21-003246
Filing Date
2021-05-17
Accepted
2021-05-17 09:00:56
Documents
115
Period of Report
2021-03-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q curr_10q.htm 10-Q 888249
2 CERTIFICATION curr_ex311.htm EX-31.1 9391
3 CERTIFICATION curr_ex312.htm EX-31.2 10271
4 CERTIFICATION curr_ex321.htm EX-32.1 4230
5 CERTIFICATION curr_ex322.htm EX-32.2 4123
12 curr_10qimg1.jpg GRAPHIC 2910
  Complete submission text file 0001477932-21-003246.txt   7168006

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT curr-20210331.xml EX-101.INS 1397834
7 XBRL TAXONOMY EXTENSION SCHEMA curr-20210331.xsd EX-101.SCH 114624
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE curr-20210331_lab.xml EX-101.LAB 557451
9 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE curr-20210331_cal.xml EX-101.CAL 81848
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE curr-20210331_pre.xml EX-101.PRE 530411
11 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE curr-20210331_def.xml EX-101.DEF 338203
Mailing Address 1620 BEACON PLACE OXNARD CA 93033
Business Address 1620 BEACON PLACE OXNARD CA 93033 805-824-0410
Cure Pharmaceutical Holding Corp. (Filer) CIK: 0001643301 (see all company filings)

IRS No.: 371765151 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-55908 | Film No.: 21927906
SIC: 2834 Pharmaceutical Preparations